Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2159 per EA under NDC 70954041340. Its NADAC has been published 145 times since Nov 16, 2022.

The High Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.2159per EA
High Outlier

Strength

5; 6.25 mg/1; mg/1

NDC

70954041340

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

8/20/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA215562

On Market Since

11/4/2021

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB has been published 145 times since Nov 16, 2022, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2159 per EA
All-time high$0.3126 (Nov 16, 2022)
All-time low$0.1467 (Nov 20, 2024)
52-week high$0.2229
52-week low$0.2159
Median price$0.2434
Average price$0.2341
Largest weekly change-32.1% (Nov 20, 2024)
Weeks tracked145
Tracking sinceNov 16, 2022

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-1.8%

3Y

-16.0%

5Y

N/A

All

-30.9%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.2159 per EA (NDC 70954041340), effective Aug 20, 2025.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB has declined 30.9%. It has been tracked across 145 weekly CMS publications since Nov 16, 2022.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

Since Nov 16, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB has ranged from a low of $0.1467 (Nov 20, 2024) to a high of $0.3126 (Nov 16, 2022), with a median of $0.2434 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB, is $0.2045 per EA — about 5% below BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB (NDC 70954041340) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.